Evogene Ltd.
EVGN- Exchange
- Nasdaq
- Industry
- Agricultural Chemicals
- SEC CIK
- 0001574565
In the last 90 days, Evogene Ltd. insiders filed 3 open-market purchases and 0 sales; 13 institutions reported holding it in 13F filings for Q2 2026, worth $120.0K in total; no superinvestor holds it.
Q1 2025 vs. Q4 2024
How the institutions holding Evogene Ltd. changed between Q4 2024 and Q1 2025.
All holders in Q1 2025All holders in Q4 2024
| Measure | Q4 2024 | Q1 2025 | Change |
|---|---|---|---|
| Holders | 15 | 16 | +1 |
| Shares | 401.9K | 421.3K | +19.4K (+4.8%) |
| Value | $751.6K | $526.9K | −$224.7K (−29.9%) |
New holders (3)
Institutions that held Evogene Ltd. at the end of Q1 2025 but not at the end of Q4 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| XTX Topco Ltd | 10,179 | $12.9K | 0.00% |
| Tidemark, LLC | 30 | $38 | 0.00% |
| US Bancorp | 15 | $19 | 0.00% |
Sold out (2)
Institutions that held Evogene Ltd. at the end of Q4 2024 and filed for Q1 2025 without it.
| Institution | Shares, Q4 2024 | Value, Q4 2024 |
|---|---|---|
| Citadel Advisors LLC | 15,891 | $29.7K |
| Synergy Financial Management, LLC | 20 | $61 |